Marksans Pharma Limited
MARKSANS.NS
NSE
205.58INR11.43 (6.52%)

Historical Prices

About

CEO
Mr. Mark B. Saldanha
Sector
Healthcare
Industry
Drug Manufacturers - General
Website
https://marksanspharma.com
Exchange
NSE
Description
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
CIK
ISININE750C01026
CUSIPY57686100
AddressGrandeur HN
Phone91 22 4001 2000
Country IN
Employee1141
IPO Date2002-07-19

Sector Weightings

Country Weightings

Financial Statement

Earnings

Financial Summary

CIK
ExchangeNSE
IndustryDrug Manufacturers - General
SectorHealthcare
CUSIPY57686100
ISININE750C01026
CountryIN
Price205.58
Beta1.665
Volume Avg.1.37M
Market Cap93.16B
Shares-
52-Week130-358.7
DCF0
ROE-
ROA-
Operating Margin-
Debt/Equity-
P/E25.55
P/B-
Websitehttps://marksanspharma.com

Upgrades and Downgrades

Rating Distribution
Buy 0Hold 0Sell 0
We are unable to load the data!

Latest News